Market Cap (In JPY)
36.73 Billion
Revenue (In JPY)
23.1 Million
Net Income (In JPY)
-632.18 Million
Avg. Volume
384.26 Thousand
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1940.0-10050.0
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- JP3266030000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Takayuki Kusanagi
- Employee Count
- -
- Website
- https://cuorips.co.jp
- Ipo Date
- 2023-06-27
- Details
- Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan.
More Stocks
-
TRUIF
-
MSMGFGrid Metals Corp.
MSMGF
-
EME
-
TECHNOE
-
ACCACC Limited
ACC
-
CKG
-
ALRPR
-
SANSERASansera Engineering Limited
SANSERA